Hyaluronidase Recombinant Human Patent Expiration
Hyaluronidase Recombinant Human was first introduced by Halozyme Therapeutics Inc
Hyaluronidase Recombinant Human Patents
Given below is the list of patents protecting Hyaluronidase Recombinant Human, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hylenex Recombinant | US7767429 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof | Sep 23, 2027 | Halozyme Therap |
Hyaluronidase Recombinant Human's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List